SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-051536
Filing Date
2018-08-13
Accepted
2018-08-13 17:13:48
Documents
76
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14076_110q.htm 10-Q 1625152
2 EX-10.2 a18-14076_1ex10d2.htm EX-10.2 285001
3 EX-31.1 a18-14076_1ex31d1.htm EX-31.1 10090
4 EX-31.2 a18-14076_1ex31d2.htm EX-31.2 10064
5 EX-32.1 a18-14076_1ex32d1.htm EX-32.1 6071
6 EX-32.2 a18-14076_1ex32d2.htm EX-32.2 6070
  Complete submission text file 0001104659-18-051536.txt   8773036

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT jagx-20180630.xml EX-101.INS 1869989
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jagx-20180630.xsd EX-101.SCH 81091
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jagx-20180630_cal.xml EX-101.CAL 65639
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jagx-20180630_def.xml EX-101.DEF 385631
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT jagx-20180630_lab.xml EX-101.LAB 624028
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jagx-20180630_pre.xml EX-101.PRE 530856
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 181013322
SIC: 2834 Pharmaceutical Preparations